CN101313966B - Medicament for treating asphyxia - Google Patents

Medicament for treating asphyxia Download PDF

Info

Publication number
CN101313966B
CN101313966B CN2008101407151A CN200810140715A CN101313966B CN 101313966 B CN101313966 B CN 101313966B CN 2008101407151 A CN2008101407151 A CN 2008101407151A CN 200810140715 A CN200810140715 A CN 200810140715A CN 101313966 B CN101313966 B CN 101313966B
Authority
CN
China
Prior art keywords
parts
medicine
portions
treatment
faintness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008101407151A
Other languages
Chinese (zh)
Other versions
CN101313966A (en
Inventor
郭龙锁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2008101407151A priority Critical patent/CN101313966B/en
Publication of CN101313966A publication Critical patent/CN101313966A/en
Application granted granted Critical
Publication of CN101313966B publication Critical patent/CN101313966B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a medicine for treating asphyxia. The invention relates to the medicine, which is characterized in that the medicine is prepared by the following raw materials by weight portion: 25 to 35 portions of rhizoma arisaematis, 25 to 35 portions of tooth soap, 0.2 to 0.8 portion of storax, 0.2 to 0.8 portion of borneol, 1.5 to 4.5 portions of wrinkled gianthyssop, 8 to 12 portions of calculus bovis and 0.2 to 0.8 portion of cinnabar. Moreover, 8 to 12 portions of medical stones can also be added into the raw materials. When the medicine is manufactured, various raw materials are ground into fine powder on a stone mill and mixed, and then the finished medicine is obtained. 'Huichun capsules' manufactured by adoption of the method provided by the invention can be used for treating various asphyxias, hypertension and various pains, and have a simple method, small dosage, short treatment period, good effect and low cost, and patients are painless. The medicine is suitable for wide consumers, particularly low-income patients.

Description

A kind of medicine for the treatment of faintness
Technical field:
The present invention relates to medicine, particularly the treatment faintness of the method medication that sucks or be blown into by the nostril and the Chinese medicine of hypertension and various pain.
Background technology:
Tackle various stupors, shock, during the stupor introduced as myocardial infarction, coronary heart disease, hypertension, cerebral hemorrhage, cerebral thrombosis, cerebral concussion etc., generally adopting Western medicine.Its shortcoming is: produce the Western medicine complex process, and the cost height, side effect is big, and effect is undesirable.Difficult its high expense of bearing of low-income household particularly.
In addition, hypertension, and various pain (headache, have a stomach-ache, have a toothache, take on painful etc.) are having a strong impact on people's life, and it is good still not have therapeutic effect at present, the specific medicament that expense is low.
Summary of the invention:
Purpose of the present invention just provides a kind of medicine for the treatment of faintness, can be used for treating various faintnesses, hypertension and various pain, and its method is simple, and dosage is little, and the treatment phase is short, and is effective, patient's no pain, and expense is low.
The objective of the invention is to realize by following scheme: a kind of medicine for the treatment of faintness is characterized in that it being that raw material by following weight portion is made: 25~35 parts of Rhizoma Arisaematiss, 25~35 parts of Fructus Gleditsiae Abnormalis, 0.2~0.8 part of Styrax, 0.2~0.8 part of Borneolum Syntheticum, 1.5~4.5 parts of Herba Pogostemoniss, 8~12 parts of Calculus Boviss, 0.2~0.8 part in Cinnabaris.
Preferable range is: 28~32 parts of Rhizoma Arisaematiss, 28~32 parts of Fructus Gleditsiae Abnormalis, 0.4~0.6 part of Styrax, 0.4~0.6 part of Borneolum Syntheticum, 2.5~3.5 parts of Herba Pogostemoniss, 9~11 parts of Calculus Boviss, 0.4~0.6 part in Cinnabaris.
Preferred plan is: 30 parts of Rhizoma Arisaematiss, 30 parts of Fructus Gleditsiae Abnormalis, 0.5 part of Styrax, 0.5 part of Borneolum Syntheticum, 3 parts of Herba Pogostemoniss, 10 parts of Calculus Boviss, 0.5 part in Cinnabaris.
Each amounts of components of raw material of the present invention can also be:
25~35 parts of Rhizoma Arisaematiss, 25~35 parts of Fructus Gleditsiae Abnormalis, 0.2~0.8 part of Styrax, 0.2~0.8 part of Borneolum Syntheticum, 1.5~4.5 parts of Herba Pogostemoniss, 8~12 parts of Calculus Boviss, 0.2~0.8 part in Cinnabaris, 8~12 parts of Maifanitums.
Preferable range is: 28~32 parts of Rhizoma Arisaematiss, 28~32 parts of Fructus Gleditsiae Abnormalis, 0.4~0.6 part of Styrax, 0.4~0.6 part of Borneolum Syntheticum, 2.5~3.5 parts of Herba Pogostemoniss, 9~11 parts of Calculus Boviss, 0.4~0.6 part in Cinnabaris, 9~11 parts of Maifanitums.
Preferred plan is: 30 parts of Rhizoma Arisaematiss, 30 parts of Fructus Gleditsiae Abnormalis, 0.5 part of Styrax, 0.5 part of Borneolum Syntheticum, 3 parts of Herba Pogostemoniss, 10 parts of Calculus Boviss, 0.5 part in Cinnabaris, 10 parts of Maifanitums.
During making, each raw material is ground to form fine powder in advance on stone grinder, mix again, be patent medicine.
The present invention has significant effect: " resuscitation powder " that adopt method provided by the invention to make can be used for treating various faintnesses, hypertension and various pain, and method is simple, and dosage is little, the treatment phase is short, and instant effect (30 seconds can take effect) is effective, patient's no pain, expense is low.Be fit to consumers in general, particularly low income patient.
The specific embodiment:
Below in conjunction with embodiment the present invention is done further narration:
Embodiment 1: select 26 parts of Rhizoma Arisaematiss, 26 parts of Fructus Gleditsiae Abnormalis (Fructus Gleditsiae Abnormalis, Fructus Gleditsia), 0.3 part of Styrax, 0.3 part of Borneolum Syntheticum, 1.8 parts of Herba Pogostemoniss, 8.5 parts of Calculus Boviss, 0.3 part in Cinnabaris, during making, each crude drug mixes, and grinds to form fine powder on stone grinder, is patent medicine.Also each raw material can be worn into fine powder in advance, mix again.During use medicated powder is sucked in (or being blown into) nose.
Embodiment 2: select 33 parts of Rhizoma Arisaematiss, 34 parts of Fructus Gleditsiae Abnormalis, 0.7 part of Styrax, 0.7 part of Borneolum Syntheticum, 4 parts of Herba Pogostemoniss, 11 parts of Calculus Boviss, 0.7 part in Cinnabaris.Making and use method is with embodiment 1.
Embodiment 3: select 28.5 parts of Rhizoma Arisaematiss, 28 parts of Fructus Gleditsiae Abnormalis, 0.4 part of Styrax, 0.4 part of Borneolum Syntheticum, 2.5 parts of Herba Pogostemoniss, 9 parts of Calculus Boviss, 0.4 part in Cinnabaris.Making and use method is with embodiment 1.
Embodiment 4: select 26 parts of Rhizoma Arisaematiss, 26 parts of Fructus Gleditsiae Abnormalis, 0.3 part of Styrax, 0.3 part of Borneolum Syntheticum, 2 parts of Herba Pogostemoniss, 8 parts of Calculus Boviss, 0.3 part in Cinnabaris, 8 parts of Maifanitums.Making and use method is with embodiment 1.
Embodiment 5: select 34 parts of Rhizoma Arisaematiss, 34 parts of Fructus Gleditsiae Abnormalis, 0.7 part of Styrax, 0.7 part of Borneolum Syntheticum, 4 parts of Herba Pogostemoniss, 11 parts of Calculus Boviss, 0.7 part in Cinnabaris, 12 parts of Maifanitums.Making and use method is with embodiment 1.
Embodiment 6: 30 parts of Rhizoma Arisaematiss, 30 parts of Fructus Gleditsiae Abnormalis, 0.5 part of Styrax, 0.5 part of Borneolum Syntheticum, 3 parts of Herba Pogostemoniss, 10 parts of Calculus Boviss, 0.5 part in Cinnabaris, 10 parts of Maifanitums.Making and use method is with embodiment 1.
Testing data:
1, cures mainly
The faintness that a variety of causes causes, hypertension, various pain (headache, have a stomach-ache, have a toothache, take on painful etc.).
2, Therapeutic Method
Be blown in the nose, or suck in the nose, one time 1~3 milligram.
3, therapeutic effect
The present invention observes case 353 people.Wherein, male 191 people, women 162 people, 42 examples below 20 years old, 21~30 years old 56 example, 31~40 years old 59 example, 41~50 years old 61 example, 51~60 years old 67 example, 68 examples more than 60 years old; Minimum 8 years old of age, maximum 76 years old.169 examples of wherein fainting are cured 147 examples, invalid 22 examples; Hypertension 63 examples are cured 59 examples, effective 4 examples, invalid 0 example; Various pain 121 examples are cured 104 examples, effective 17 examples, invalid 0 example.
Concrete case:
1, Guo so-and-so, the man, 68 years old, people from village that appear on the stage in the Gong Shui town of Linzhou City, Henan Province, because of cerebral thrombosis causes the faintness state, revived no sequel on November 27th, 1999 through medication.
2, the Qin so-and-so, the man, 10 years old, the sloping people of mulberry leaf harvest township, Linzhou City, Henan Province Qin man fainted suddenly on January 5th, 1997, revived no sequel through medication.
3, Ma, the man, 45 years old, the cadre of Linzhou City, Henan Province law court, on August 10th, 1992 hypertension, high pressure reaches 180, through medication, drops to 160 in 3 minutes, and does not have an attack of one's old illness again.
4, the king so-and-so, the woman, 60 years old, Wan Zhong township, Pingyu County, Henan Province Wan Zhai people from village, the headache several years, treat in this punishment when in March, 1993 calls on relatives in Linzhou City, inhale once, headache disappears, and does not have an attack of one's old illness again.
5, cattle so-and-so, the man, 56 years old, had a stomach-ache on June 2nd, 1991, come to go to a doctor upon somebody's introduction, hear medicine and took effect in 3 minutes, do not have an attack of one's old illness again more afterwards.
6, not so-and-so, the man, He Shun people from town, Linzhou City, Henan Province, it is tens of day to have a toothache, medication 3 minutes is cured.
In the prescription of the present invention, Rhizoma Arisaematis drying dampness to eliminate phlegm, expelling wind for relieving convulsion, dispersing swelling and dissipating binds.Cure mainly, middle wind-phlegm is stopped up, deviation of the eye and mouth, and hemiplegia, epilepsy, infantile convulsion, tetanus, dizziness due to wind-phlegm, sore throat, scrofula, carbuncle falls and pounces on folding wound, snake bite and insect sting.Modern medicine study shows that Rhizoma Arisaematis has convulsion, calm, analgesia, effect such as eliminate the phlegm.
Fructus Gleditsiae Abnormalis eliminates the phlegm, has one's ideas straightened out, and is mainly used in treatment: 1, cold-damp stop up to stagnate, uncomfortable in chestly breath with cough, abundant expectoration and cough up and tell not well person.2, suddenly go into a coma, locked mouth is not opened, and the epilepsy abundant expectoration, closes the disease that the key resistance is closed.
Styrax is sensible, wards off dirty parasite killing, dissipating depression and eliminating phlegm, promoting flow of QI and blood, inducing diuresis to remove edema.Be used for the treatment of the soldier and so faint, expectorant is stopped up the , Jing Epilepsy of losing consciousness, convulsive diseases, pyrexial malaria, the sudden pain of trusted subordinate, scabies, rash miliaria, chilblain, QI-mass mass formed by blood stasis, breast abdomen cold type of pain, QI rising in reverse order gastralgia, watery distension.
The Borneolum Syntheticum refreshment of having one's ideas straightened out, the stagnated fire of loosing, removing nebula makes eye bright, reducing swelling and alleviating pain.Cure mainly: apoplexy locked mouth, calentura coma , Jing Epilepsy expectorant fan, deafness with qi stagnation, sore throat, aphtha, otitis media, carbuncle, hemorrhoid, conjunctivitis, enterobiasis.Modern medicine study shows that it has anti-myocardial infarction, pain relieving and anticorrosion, effects such as inhibiting bacteria and diminishing inflammation.
Herba Pogostemonis regulate the flow of vital energy and in, ward off dirty, damp eliminating.Cure mainly the flu heat-damp in summer, cold ripe, headache, breast amine painful abdominal mass is vexed, and vomiting is had loose bowels, malaria, dysentery, halitosis.
Calculus Bovis clears away heart-fire, and eliminating phlegm is had one's ideas straightened out, cool liver, endogenous wind stopping, detoxifcation.Be used for the calentura coma, middle wind-phlegm fan, infantile convulsion is twitched, and epilepsy is gone mad, laryngopharynx swelling and pain, aphtha of the mouth and tongue, carbuncle furuncle.Modern medicine study shows: it has following effect: 1, clear away heart-fire, cool liver, the effect of expellingging wind and relieving convulsion, calming the frightened and calming the nerves is arranged.The high fever coma that is used for epidemic febrile disease and infantile convulsion, the diseases such as tic of fainting from fear.2, the heat that can clear away heart-fire can be reduced phlegm again, the refreshment of having one's ideas straightened out.Be used for the epidemic febrile disease heat attacking the pericardium, apoplexy, infantile convulsion, the hot person of outstanding talent of expectorant such as crazy pain is covered diseases such as coma due to the thinking, locked mouth, rale.3, heat-clearing and toxic substances removing power is strong, with heat-clearing and toxic substances removing, blood circulation promoting and dispersing pathogen accumulation.Be used for laryngopharynx swelling and pain, fester and carbuncle is treated pyretic toxicity such as poison and stopped up the disease of pent-ups that stagnates.
Cinnabaris clears away heart-fire relieving convulsion, the detoxifcation of calming the nerves.Be mainly used in treatment: 1, malaise, cardiopalmus, insomnia.But both tranquillization with heavy prescription again can clearing away heart-fire for tranquillization, the malaise of the suitableeest hyperactivity of heart-fire, irritated sleeplessness.2, infantile convulsion, epilepsy.The merit that tranquillizing the mind by relieving convulsion is arranged.With controlling unconsciousness due to high fever, convulsions.3, sore swollen toxin, laryngopharynx swelling and pain, aphtha of the mouth and tongue.Stronger antipyretic and antidote functions is arranged, and for oral administration, external is all imitated.
Maifanitum is a kind of natural medicine Ore, contains 18 kinds of trace element such as the necessary potassium of human body, sodium, calcium, magnesium, phosphorus macroelement and zinc, ferrum, selenium, copper, strontium, iodine, fluorine, metasilicic acid.Maifanitum can utilize self component to remove noxious substance by the method that absorbs, decomposes.The various trace element and the mineral that discharge are the important component of keeping some functional materials of body special physiological function, as transport the hemoglobin of oxygen and participate in energy metabolism, keep the body acid-base balance, keep histiocyte osmotic pressure etc.
Patient often faints because of experiencing the cold-evil, or phlegm-damp, or foul not just gas, so that inaccessible mechanism of qi, hoodwinks due to the gods.In the side Styrax, Borneolum Syntheticum have one's ideas straightened out ward off dirty, promoting flow of QI and blood; Rhizoma Arisaematis, Fructus Gleditsiae Abnormalis reducing phlegm, expelling pathologic wind, dispersing swelling and dissipating binds; Herba Pogostemonis regulate the flow of vital energy and in, ward off dirty damp eliminating; The Cinnabaris tranquilizing mind, heat-clearing and toxic substances removing; Calculus Bovis endogenous wind stopping relieving convulsion, detoxicating and resolving stagnation of pathogens; Maifanitum detoxifcation energy supply, adjustment.All medicines are combined into and sensiblely reduce phlegm, endogenous wind stopping circulation of qi promoting, refreshment and tranquilization, blood circulation promoting and dispersing pathogen accumulation, the detoxifcation of dispeling the wind, regulate the agent of negative and positive.

Claims (5)

1. medicine for the treatment of faintness is characterized in that it being that raw material by following weight portion is made: 25~35 parts of Rhizoma Arisaematiss, 25~35 parts of Fructus Gleditsiae Abnormalis, 0.2~0.8 part of Styrax, 0.2~0.8 part of Borneolum Syntheticum, 1.5~4.5 parts of Herba Pogostemoniss, 8~12 parts of Calculus Boviss, 0.2~0.8 part in Cinnabaris.
2. a kind of medicine for the treatment of faintness according to claim 1 is characterized in that crude drug also has: Maifanitum 8~12.
3. a kind of medicine for the treatment of faintness according to claim 1 is characterized in that the component of each crude drug is: 30 parts of Rhizoma Arisaematiss, 30 parts of Fructus Gleditsiae Abnormalis, 0.5 part of Styrax, 0.5 part of Borneolum Syntheticum, 3 parts of Herba Pogostemoniss, 10 parts of Calculus Boviss, 0.5 part in Cinnabaris.
4. a kind of medicine for the treatment of faintness according to claim 3 is characterized in that crude drug also has: Maifanitum 10.
5. according to claim 1 or 2 or 3 or 4 described a kind of manufacture methods for the treatment of the medicine of faintness, it is characterized in that: during making, each raw material is ground to form fine powder in advance on stone grinder, mix again, be patent medicine.
CN2008101407151A 2008-07-21 2008-07-21 Medicament for treating asphyxia Expired - Fee Related CN101313966B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008101407151A CN101313966B (en) 2008-07-21 2008-07-21 Medicament for treating asphyxia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008101407151A CN101313966B (en) 2008-07-21 2008-07-21 Medicament for treating asphyxia

Publications (2)

Publication Number Publication Date
CN101313966A CN101313966A (en) 2008-12-03
CN101313966B true CN101313966B (en) 2010-11-10

Family

ID=40105210

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008101407151A Expired - Fee Related CN101313966B (en) 2008-07-21 2008-07-21 Medicament for treating asphyxia

Country Status (1)

Country Link
CN (1) CN101313966B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102670700A (en) * 2012-05-10 2012-09-19 梁钦 Chinese medicinal health-care medicament for arousing brain and inducing resuscitation

Also Published As

Publication number Publication date
CN101313966A (en) 2008-12-03

Similar Documents

Publication Publication Date Title
CN103893545A (en) Moxa stick for improving brain health and preparation method of moxa stick
JP5015165B2 (en) Manufacture and use of medical devices for rehabilitation of chronic diseases in alternative therapies
CN103520461B (en) Medicine for treating allergic rhinitis
CN101264146B (en) Externally-applied Chinese herbal medicine for treating bones and muscles disease and preparation thereof
CN106581454A (en) Chinese herbal medicinal composition for treating bone fracture and disorders of the neck, shoulders, loin and legs, and preparation method thereof
CN102078391A (en) Medicine for treating neck, shoulder, waist and leg pain
CN104258278B (en) Gushangling (for bone injury) spray
CN101313966B (en) Medicament for treating asphyxia
CN101703701B (en) Medicament for treating facioplegia
CN100548327C (en) Medicine for external use of treatment tickling dermatosis and preparation method thereof
CN105030901A (en) Traditional Chinese medicine composition for treatment of skin diseases and application method thereof
CN102743440B (en) Traditional Chinese medicines for treating femoral head necrosis
CN105012594A (en) Traditional Chinese medicine for treating knee osteoarthritis
CN111419924A (en) A topical Chinese medicinal composition for treating various muscle and bone diseases, and its preparation device
CN104491700A (en) Externally-applied traditional Chinese medicine for treating rheumatism nervous arthralgia and preparation method of externally-applied traditional Chinese medicine
CN1202859C (en) Chinese medicine for treating protrasion of the lumber intervertebral disci
CN105412395A (en) Traditional Chinese medicine composition for treating hyperostosis and preparation method thereof
CN101954018A (en) Oral medicament for treating chronic nephritis
CN105106590A (en) Medicine for treating allergic rhinitis
CN105832931A (en) Traditional Chinese medicine composition for externally treating hypertension and use method thereof
CN105012622A (en) Beverage for treating insomnia
CN105213658A (en) A kind of Chinese medicine lotion for the treatment of allergic eczema and preparation method thereof
CN101347459B (en) Medicine for treating cancer
CN100408073C (en) Chinese patented medicine for treating lumber spinal canal stenosis
CN104587093A (en) Topical traditional Chinese medicine powder for treating acute soft tissue injury

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101110

Termination date: 20110721